Radical treatment for oesophageal cancer patients unfit for surgery and chemotherapy. A 10-year experience from the Norwegian radium Hospital

Acta Oncologica

Volumn 49, Issue 2, 2010, Pages 209-218

  Amdal, Cecilie D ^a   Jacobsen, Anne Birgitte ^a   Tausjø, Johan E ^a   Wiig, Johan N ^a   Warloe, Trond ^a   Karlsen, Karl O ^a   Sandstad, Berit ^a   Bjordal, Kristin ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DYSPHAGIA; ESOPHAGUS CANCER; EXPERIENCE; FEMALE; HUMAN; INOPERABLE CANCER; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PREOPERATIVE CARE; PRIORITY JOURNAL; SYMPTOM; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; RADIOTHERAPY;

EID: 76649144194     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841860903246573     Document Type: Article

References (25)

1. The Cancer Registry of Norway. Cancer in Norway 2001.
2. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma:A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-10.
3. Mala T, Løtveit T. Surgical treatment of oesophageal cancer. Tidsskr Nor Laegeforen. 2001;121:2815-7.
4. Ask A, Albertsson M, Järhult J, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in oesophageal cancer. Acta Oncol 2003;42:462-75. Review.
5. Koshy M, Esiashvilli N, Landry JC, Thomas CR, Matthews RH. Multiple management modalities in esophageal cancer:Epidemiology, presentation and progression, work-up, and surgical approaches. Oncologist 2004;9:137-46.
6. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma:I. A critical review of surgery. Br J Surg 1980;67:381-90.
7. Sykes AJ, Burt PA, Slevin NJ, Stout R, Marrs JE. Radical radiotherapy for carcinoma of the oesophagus:An effective alternative to surgery. Radiother Oncol 1998;48:15-21.
8. Ekman S, Dreilich M, Lennartsson J, Wallner B, Brattström D, Sundbom M, et al. Esophageal cancer:Current and emerging therapy modalities. Expert Rev Anticancer Ther 2008;9:1433-48.
9. Hatlevoll R, Hagen S, Hansen HS, Hultborn R, Jakobsen A, Mäntylä M, et al. Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. A prospective randomized multicentre study:The second Scandinavian trial in esophageal cancer. Radiother Oncol 1992;24:114-6.
10. Wobbes T, Baron B, Paillot B, Jacob JH, Haegele P, Gignoux M, et al. Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus. Eur J Cancer 2001;37:470-7.
11. Nishimura Y, Ono K, Tsutsui K, Oya N, Okajima K, Hiraoka M, et al. Esophageal cancer treated with radiotherapy:Impact of total treatment time and fractionation. Int J Radiat Oncol Biol Phys 1994;30:1099-105.
12. Statistics Norway. www.statbank.ssb.no.
13. Stockeld D, Backman L, Fagerberg J, Granström L. Esophageal cancer in Stockholm county 1978-1995. Acta Oncol 2007;46:1075-84.
14. Leslie MD, Dische S, Saunders MI, Grosch E, Fermont D, Ashford RF, et al. The role of radiotherapy in carcinoma of the thoracic oesophagus:An audit of the Mount Vernon experience 1980-1989. Clin Oncol (R Coll Radiol) 1992;4:114-8.
15. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preop-erative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-13.
16. Neuhof D, Neumayer F, Einbeck W, Haschemian K, Mai SK, Hochhaus A, et al. Retrospective evaluation of combined modality treatment and prognostic factors in patients with esophageal cancer. Acta Oncol 2005;44:168-73.
17. Walsh TN, Noonan N, Hollywood DA, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7.
18. Churn M, Jones B, Myint AS. Radical radiotherapy incorporating a brachytherapy boost for the treatment of carcinoma of the thoracic oesophagus:Results from a cohort of patients and review of the literature. Clin Oncol (R Coll Radiol) 2002;14:117-22.
19. Hishikawa Y, Kurisu K, Taniguchi M, Kamikonya N, Miura T. High-dose-rate intraluminal brachytherapy for esophageal cancer:10 years experience in Hyogo College of Medicine. Radiother Oncol 1991;21:107-14. Review.
20. Shi XH, Yao W, Liu T. Late course accelerated fractionation in radiotherapy of esophageal carcinoma. Radiother Oncol 1999;51:21-6.
21. Zhao KL, Shi XH, Jiang GL, Wang Y. Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma. Int J Radiat Oncol Biol Phys 2004;60:123-9.
22. Wang Y, Shi XH, He SQ, Yao WQ, Wang Y, Guo XM, et al. Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 2002;54:131-6.
23. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
24. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Ritsuko K, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer:High-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1151-3.
25. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer:An intergroup study. J Clin Oncol 1997;15:277-84.